- Home
- TCRX vs RFM Comparison
TCRX vs RFM Comparison
Compare TCRX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- RFM
- Stock Information
- Founded
- TCRX 2018
- RFM 2020
- Country
- TCRX United States
- RFM United States
- Employees
- TCRX N/A
- RFM N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- TCRX Health Care
- RFM Finance
- Exchange
- TCRX Nasdaq
- RFM Nasdaq
- Market Cap
- TCRX 91.7M
- RFM 85.5M
- IPO Year
- TCRX 2021
- RFM N/A
- Fundamental
- Price
- TCRX $1.79
- RFM $13.97
- Analyst Decision
- TCRX Strong Buy
- RFM
- Analyst Count
- TCRX 6
- RFM 0
- Target Price
- TCRX $9.50
- RFM N/A
- AVG Volume (30 Days)
- TCRX 255.2K
- RFM 20.7K
- Earning Date
- TCRX 08-12-2025
- RFM 01-01-0001
- Dividend Yield
- TCRX N/A
- RFM 9.74%
- EPS Growth
- TCRX N/A
- RFM N/A
- EPS
- TCRX N/A
- RFM N/A
- Revenue
- TCRX $6,961,000.00
- RFM N/A
- Revenue This Year
- TCRX $159.20
- RFM N/A
- Revenue Next Year
- TCRX N/A
- RFM N/A
- P/E Ratio
- TCRX N/A
- RFM N/A
- Revenue Growth
- TCRX N/A
- RFM N/A
- 52 Week Low
- TCRX $1.02
- RFM $12.89
- 52 Week High
- TCRX $6.23
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- TCRX 54.34
- RFM 50.17
- Support Level
- TCRX $1.60
- RFM $14.05
- Resistance Level
- TCRX $1.86
- RFM $14.20
- Average True Range (ATR)
- TCRX 0.10
- RFM 0.11
- MACD
- TCRX 0.00
- RFM 0.02
- Stochastic Oscillator
- TCRX 70.37
- RFM 54.90
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.